Harrow (HROW) News Today $45.43 -2.30 (-4.82%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$45.46 +0.03 (+0.07%) As of 10/3/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Harrow Dropping Today?Toggle Visibility of Why Is Harrow Dropping Today?Harrow, Inc. (NASDAQ: HROW) shares are down today as investors digest a mix of analyst forecast revisions. While B. Riley reiterated a bullish long-term outlook, cuts to near-term earnings estimates weighed on sentiment. Positive Sentiment: B. Riley Securities reiterated its “Buy” rating on Harrow. B. Riley Securities Reiterates Harrow (HROW) Buy Recommendation Positive Sentiment: B. Riley raised its FY2027 EPS forecast to $4.34 from $4.16. Free Report Neutral Sentiment: B. Riley provided predictions for Harrow’s Q4 earnings without changing its “Buy” rating. B. Riley Predicts Harrow's Q4 Earnings (NASDAQ:HROW) Neutral Sentiment: William Blair issued a FY2025 earnings estimate for Harrow. FY2025 Earnings Estimate for Harrow Issued By William Blair Negative Sentiment: B. Riley cut its Q3 2025 EPS estimate to $0.33 from $0.36. Research Analysts Issue Forecasts for Harrow Q3 Earnings Negative Sentiment: B. Riley trimmed its FY2025 EPS outlook to $0.82 from $0.93. Free Report Negative Sentiment: B. Riley lowered its FY2026 EPS forecast to $2.86 from $2.88. Free Report Negative Sentiment: B. Riley cut its Q4 2025 EPS estimate to $0.55 from $0.63. B. Riley Comments on Harrow's Q4 Earnings (NASDAQ:HROW) Posted 20h agoAI Generated. May Contain Errors. HROW Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Harrow (NASDAQ:HROW) Trading Down 4.9% - Should You Sell?October 3 at 6:08 PM | marketbeat.comResearch Analysts Issue Forecasts for Harrow Q3 EarningsOctober 3 at 6:50 AM | marketbeat.comB. Riley Predicts Harrow's Q4 Earnings (NASDAQ:HROW)October 3 at 2:31 AM | americanbankingnews.comB. Riley Comments on Harrow's Q4 Earnings (NASDAQ:HROW)October 2 at 7:46 AM | marketbeat.comB. Riley Securities Reiterates Harrow (HROW) Buy RecommendationOctober 2 at 2:38 AM | msn.comFY2025 Earnings Estimate for Harrow Issued By William BlairOctober 2 at 2:19 AM | americanbankingnews.comHarrow price target raised to $74 from $70 at B. RileyOctober 1 at 4:47 PM | msn.comWilliam Blair Issues Positive Outlook for Harrow EarningsOctober 1 at 6:23 AM | marketbeat.comWhat is William Blair's Estimate for Harrow FY2025 Earnings?September 30, 2025 | marketbeat.comLake Street Maintains Harrow (HROW) Buy RecommendationSeptember 30, 2025 | msn.comHarrow's (HROW) "Buy" Rating Reaffirmed at HC WainwrightSeptember 30, 2025 | americanbankingnews.comHC Wainwright & Co. Reiterates Harrow (HROW) Buy RecommendationSeptember 29, 2025 | msn.comHarrow (NASDAQ:HROW) Shares Gap Up - Still a Buy?September 29, 2025 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Harrow (NASDAQ:HROW)September 29, 2025 | marketbeat.comHarrow Health Secures New $40 Million Credit FacilitySeptember 29, 2025 | tipranks.comMaridea Wealth Management LLC Invests $202,000 in Harrow, Inc. $HROWSeptember 27, 2025 | marketbeat.comHarrow, Inc. (HROW) Analyst/Investor Day TranscriptSeptember 27, 2025 | seekingalpha.comHarrow to buy Melt PharmaceuticalsSeptember 26, 2025 | msn.comCould Harrow's New Sedation Pill Change Millions Of Medical Procedures Forever?September 26, 2025 | finance.yahoo.comHarrow Health Hosts Investor Day PresentationSeptember 26, 2025 | tipranks.comCould Harrow's New Sedation Pill Change Millions Of Medical Procedures Forever?September 26, 2025 | benzinga.comHarrow to Acquire Melt PharmaceuticalsSeptember 26, 2025 | globenewswire.comB. Riley Comments on Harrow's FY2025 Earnings (NASDAQ:HROW)September 26, 2025 | americanbankingnews.comBTIG Research Reaffirms "Buy" Rating for Harrow (NASDAQ:HROW)September 26, 2025 | americanbankingnews.comB. Riley Has Positive Estimate for Harrow Q3 EarningsSeptember 26, 2025 | americanbankingnews.comHarrow Launches Harrow Access for All (HAFA)September 25, 2025 | globenewswire.comB. Riley Weighs in on Harrow's Q3 Earnings (NASDAQ:HROW)September 25, 2025 | marketbeat.comBrokerages Set Harrow, Inc. (NASDAQ:HROW) Target Price at $64.67September 25, 2025 | americanbankingnews.comHarrow's (HROW) Buy Rating Reaffirmed at BTIG ResearchSeptember 24, 2025 | marketbeat.comB. Riley Predicts Harrow's FY2025 Earnings (NASDAQ:HROW)September 24, 2025 | marketbeat.comHarrow price target raised to $64 from $54 at Craig-HallumSeptember 24, 2025 | msn.comDemystifying Harrow: Insights From 5 Analyst ReviewsSeptember 24, 2025 | benzinga.comHarrow (NASDAQ:HROW) Price Target Raised to $70.00 at B. RileySeptember 24, 2025 | americanbankingnews.comHarrow (NASDAQ:HROW) Stock Price Expected to Rise, B. Riley Analyst SaysSeptember 23, 2025 | marketbeat.comHarrow (NASDAQ:HROW) Trading 7.1% Higher After Analyst UpgradeSeptember 23, 2025 | marketbeat.comHarrow (NASDAQ:HROW) Price Target Raised to $64.00 at Craig HallumSeptember 23, 2025 | marketbeat.comHarrow, Inc. (NASDAQ:HROW) Receives Average Rating of "Moderate Buy" from AnalystsSeptember 20, 2025 | marketbeat.comGoldman Sachs Group Inc. Trims Stock Holdings in Harrow, Inc. $HROWSeptember 19, 2025 | marketbeat.comVoya Investment Management LLC Boosts Stock Position in Harrow, Inc. $HROWSeptember 17, 2025 | marketbeat.comHarrow Health (HROW) Receives a Buy from Lake StreetSeptember 16, 2025 | theglobeandmail.comHarrow (NASDAQ:HROW) Trading 7.3% Higher - Here's WhySeptember 16, 2025 | marketbeat.comHarrow Announces Agenda and Speakers for Investor & Analyst DaySeptember 15, 2025 | globenewswire.comWilliam Blair Analysts Lower Earnings Estimates for HarrowSeptember 13, 2025 | marketbeat.comHarrow Health Completes $250M Senior Notes SaleSeptember 12, 2025 | tipranks.comHarrow: Buy A Blend Of Value And GrowthSeptember 12, 2025 | seekingalpha.comTrexquant Investment LP Sells 84,853 Shares of Harrow, Inc. $HROWSeptember 12, 2025 | marketbeat.comHarrow (HROW) Launches US$250M Senior Notes Offering To Refinance DebtSeptember 11, 2025 | finance.yahoo.comHarrow (NASDAQ:HROW) Shares Gap Up - Here's WhySeptember 10, 2025 | marketbeat.comHarrow: A Classical GARP StockSeptember 9, 2025 | seekingalpha.comHarrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030September 8, 2025 | globenewswire.com Get Harrow News Delivered to You Automatically Sign up to receive the latest news and ratings for HROW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HROW Media Mentions By Week HROW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HROW News Sentiment▼0.510.53▲Average Medical News Sentiment HROW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HROW Articles This Week▼297▲HROW Articles Average Week Get the Latest News and Ratings for HROW and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Harrow and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Grifols News Rhythm Pharmaceuticals News Avidity Biosciences News Abivax News Legend Biotech News Cytokinetics News Nuvalent News Axsome Therapeutics News TG Therapeutics News CRISPR Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HROW) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredLost Decade warning – do this nowWith the Magnificent 7 trading at bubble-like valuations, another “Lost Decade” could be looming — but Porter ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harrow, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harrow With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
